Diabetes and cognitive disorders:
understanding the link and adapting practice
Neurobiological mechanisms, screening, adaptation of care, cognitive stimulation — the complete guide for healthcare professionals and caregivers
The link between diabetes and cognitive disorders is now firmly established by scientific research — but it remains little known in daily clinical practice. However, early identification of cognitive disorders in a diabetic person profoundly changes management: it allows for the adaptation of therapeutic goals, simplifies treatment, strengthens therapeutic education, and anticipates the risks associated with the autonomous management of diabetes (missed medications, hypoglycemia, dosing errors). This guide is aimed at healthcare professionals — nurses, doctors, dietitians, pharmacists, home helpers — as well as family caregivers facing this dual reality on a daily basis.
1. The mechanisms linking diabetes and the brain
The link between diabetes and cognitive decline is not a matter of chance or the simple co-occurrence of two common pathologies in elderly people. Several direct and indirect neurobiological mechanisms explain why diabetes, and particularly poorly controlled type 2 diabetes, is an independent risk factor for dementia — whether it is Alzheimer's disease or vascular dementia.
1.1 Brain insulin resistance
Insulin not only regulates peripheral blood sugar — it plays a crucial role in the brain, particularly in the hippocampus, a central region for memory and learning. Brain insulin resistance — which often accompanies type 2 diabetes — disrupts insulin signaling in neurons, alters synaptic plasticity, and promotes the accumulation of hyperphosphorylated tau proteins, one of the neuropathological markers of Alzheimer's disease. This mechanism has led some researchers to refer to Alzheimer's disease as "type 3 diabetes."
1.2 Cerebral microvascular damage
Poorly controlled chronic diabetes progressively damages small blood vessels throughout the body — including in the brain. These cerebral microvascular damages manifest as leukoaraiosis (white matter lesions visible on MRI), silent micro-infarcts, and reduced cerebral blood flow. They constitute the main mechanism of vascular dementia in diabetic individuals and significantly contribute to cognitive disorders even outside of established dementia.
1.3 Repeated hypoglycemia: an overlooked factor
Repeated hypoglycemic episodes — common in diabetic individuals on insulin or sulfonylureas — cause cumulative neuronal damage. The brain, which relies almost exclusively on glucose as an energy fuel, is particularly vulnerable to even transient deprivation of glucose. Longitudinal studies show a correlation between the number of severe hypoglycemic events and the risk of accelerated cognitive decline.
⚠️ Vicious circle: Cognitive disorders themselves increase the risk of hypoglycemia — due to missed meals, insulin dosing errors, or the inability to recognize the warning signs of hypoglycemia. Diabetes and cognitive decline feed into each other in a vicious circle that management must seek to break.
1.4 Chronic low-grade inflammation
Type 2 diabetes is accompanied by a chronic systemic inflammatory state — hypersecretion of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) — that crosses the blood-brain barrier and maintains deleterious neuroinflammation. This neuroinflammation accelerates the progression of brain lesions and contributes to the impairment of cognitive functions, particularly memory and executive functions.
1.5 Sleep apnea: an aggravating comorbidity
Obstructive sleep apnea syndrome (OSAS) is 2 to 3 times more common in diabetic individuals than in the general population. However, OSAS itself is a major risk factor for cognitive disorders: repeated nighttime hypoxias damage hippocampal structures, disrupt nighttime memory consolidation, and promote the accumulation of beta-amyloid. Screening and treating OSAS in diabetic individuals is therefore a priority with dual benefits.
| Mechanism | Main type of diabetes involved | Affected brain structures | Type of cognitive decline |
|---|---|---|---|
| Brain insulin resistance | Type 2 | Hippocampus, prefrontal cortex | Episodic memory, executive functions |
| Microvascular damage | Type 1 and Type 2 | White matter, small vessels | Vascular dementia, processing speed |
| Repeated hypoglycemia | Type 1 and Type 2 (insulin-treated) | Hippocampus, temporal cortex | Episodic memory, learning |
| Chronic inflammation | Type 2 (especially obese) | Diffuse | Global cognitive slowing |
| Associated OSAS | Type 2 (often obese) | Hippocampus, frontal lobe | Memory, attention, executive functions |
2. What cognitive disorders to observe in diabetic individuals?
The cognitive disorders associated with diabetes are not limited to dementia — a state that represents the most advanced stage of a continuum. Most diabetic individuals exhibit mild cognitive disorders (Mild Cognitive Impairment or MCI) that do not meet the criteria for dementia but have significant clinical implications for the management of their disease.
Slowed processing speed
The brain takes longer to process information. The person is slower to respond, react, and make decisions. This slowing may go unnoticed in consultation but can have real consequences on the daily management of diabetes.
Working memory disorders
Difficulty retaining and manipulating multiple pieces of information simultaneously: following a conversation, remembering the steps of an injection protocol, adjusting their dose according to current blood sugar levels. These difficulties are often underestimated by the individual themselves.
Executive function impairment
Difficulties in planning, problem-solving, and cognitive flexibility. Directly impacts the ability to adapt one's diet, manage injections in unexpected contexts, or interpret blood sugar variations.
Attention disorders
Difficulties in maintaining attention, concentrating during a consultation, or following therapeutic education recommendations. Often worsened in cases of hypoglycemia or acute hyperglycemia, even mild.
2.1 The impact of real-time blood sugar on cognitive functions
Beyond chronic impairments, current blood sugar directly influences cognitive performance. Studies in ecological conditions show that a blood sugar level above 2 g/L or below 0.7 g/L significantly impairs working memory, processing speed, and attention capacity. These acute glycemic variations explain why the cognitive performance of a diabetic individual can fluctuate considerably from hour to hour — and why cognitive assessments should ideally be conducted in normoglycemia.
3. Screening for cognitive disorders in diabetic individuals
Screening for cognitive disorders in diabetic individuals is recommended by diabetes scientific societies (SFD, ADA) for all individuals over 65 years old or in cases of cognitive complaints. Several validated tools are available, each with specific advantages and limitations.
| Test | Duration | Evaluated domains | Alert threshold | Advantages |
|---|---|---|---|---|
| MMSE | 10 min | Orientation, memory, language, praxis | < 24/30 | Well-known, quick, usable in primary care |
| MoCA | 10 min | Executive functions, memory, visuospatial | < 26/30 | More sensitive to MCI than the MMSE |
| Clock drawing test | 2 min | Executive functions, visuoconstruction | Score < 4/5 | Simple, non-verbal, integrable into any consultation |
| 5-Word test | 5 min | Verbal episodic memory | Delayed recall < 4/5 | Very sensitive to amnesic MCI, little influenced by educational level |
| Trail Making Test | 5 min | Processing speed, cognitive flexibility | Abnormal TMT-B delay | Sensitive to frontal and vascular impairments |
Practical advice: The MoCA is currently the recommended first-line screening tool for elderly diabetic individuals, as it is more sensitive than the MMSE for detecting mild cognitive disorders, particularly impairments in executive functions common in vascular diabetes. Find DYNSEO cognitive tests at dynseo.com/nos-tests/.
🎓 DYNSEO Training — Diabetes and Cognitive Disorders: Understanding the Link and Adapting Professional Practice
This certifying training (Qualiopi), 100% online and at your own pace, is designed for healthcare professionals and caregivers who wish to understand the link between diabetes and cognitive decline, master screening tools, and adapt their practice. Fundable by OPCO.
Access the training →4. Adapting diabetes management in the presence of cognitive disorders
The presence of cognitive disorders in a diabetic individual profoundly changes therapeutic goals and management modalities. A rigorous but inflexible approach exposes the individual to iatrogenic hypoglycemia, deterioration in quality of life, and accelerated loss of autonomy. Adaptation is a clinical and ethical necessity.
4.1 Adapting glycemic goals
In elderly diabetic individuals with cognitive disorders, strict glycemic goals (HbA1c < 7%) should be relaxed. Scientific societies recommend HbA1c targets between 7.5% and 8.5% for fragile patients or those with moderate cognitive disorders, and up to 9% in cases of total dependence or severe dementia. The priority is to avoid hypoglycemia, whose cognitive and cardiovascular consequences are more severe than those of moderate hyperglycemia in this population.
4.2 Simplifying medication treatment
Reduce the number of medication doses
Polypharmacy, common in elderly diabetic individuals, is a major factor in non-adherence when cognitive disorders set in. Prefer extended-release forms (one dose per day), fixed combinations in a single tablet, and pill organizers managed by a relative or healthcare professional.
Reassess insulin and injection regimens
A complex basal-bolus regimen can become unmanageable with cognitive disorders. Consider switching to a single fixed-dose basal insulin, administered by a relative or nurse. Disposable pre-filled pens significantly simplify injection management.
Reassess the role of hypoglycemic sulfonylureas
Sulfonylureas (glibenclamide, gliclazide) expose elderly individuals with cognitive disorders to a high risk of severe hypoglycemia — especially since they may not recognize the warning signs. Their replacement with molecules that do not carry hypoglycemic risk (metformin if tolerated, DPP-4 inhibitors, SGLT2 inhibitors if appropriate) should be systematically considered.
4.3 Adapting therapeutic education (ETP)
Standard therapeutic education — based on complex messages, carbohydrate calculations, and autonomous dose adjustments — is no longer suitable in the presence of significant cognitive disorders. ETP should be redesigned around simple, few rules, repeated at each contact, and systematically integrating the main caregiver into the learning process.
🎓 Principles of an ETP adapted to cognitive disorders
Reduce the information to be conveyed to 3 or 4 absolutely essential points, use simple visual aids, repeat at each consultation rather than teaching once, check understanding by reformulation rather than by questions, involve the caregiver in each ETP session and provide them with simplified documents to keep at home.
DYNSEO Skills Tracking Table
The skills tracking table allows healthcare professionals to monitor the evolution of self-management skills for diabetes in a person with cognitive disorders: ability to measure blood sugar, recognize signs of hypoglycemia, manage injections, apply dietary instructions. An essential traceability tool for care coordination and early detection of deterioration.
Access the tool5. Cognitive stimulation in diabetes: why and how?
Regular cognitive stimulation is one of the non-drug interventions whose effectiveness is best documented for slowing cognitive decline in diabetes — on par with regular physical activity and a balanced diet. It works by strengthening cognitive reserve, stimulating neuroplasticity, and maintaining competence in the most frequently used areas on a daily basis.
5.1 Physical exercise and cognition in diabetes
Regular physical exercise (30 minutes of brisk walking 5 times a week) provides a double benefit for the diabetic person: it improves blood sugar control by increasing peripheral insulin sensitivity, and it directly stimulates hippocampal neurogenesis via the production of BDNF (Brain-Derived Neurotrophic Factor). Randomized studies show a measurable improvement in memory performance and executive functions after 12 weeks of regular exercise in elderly diabetic individuals.
5.2 Digital applications for cognitive stimulation
The SCARLETT application from DYNSEO is particularly suited for diabetic seniors: its exercises cover memory (visual, verbal, associative), attention, reasoning, and language. The simplified interface, adaptive level, and the possibility of short sessions (10 to 15 minutes) make it a usable tool even for those who are not comfortable with technology or have early cognitive disorders.
The CLINT application is suitable for younger adults or those with mild cognitive disorders, with a broader catalog of stimulating exercises and a higher level of difficulty.
DYNSEO Session Tracking Sheet
The session tracking sheet allows professionals — coordinating nurses, caregivers, home helpers — to document each cognitive stimulation or diabetes ETP session: activities performed, level of understanding, observed difficulties, blood sugar at the time of the session. An essential multidisciplinary coordination tool to optimize care.
Access the tool6. The role of family caregivers in managing diabetes with cognitive disorders
As cognitive disorders progress, the family caregiver becomes a central player in diabetes management. This transition — often gradual and informal — requires specific training and support. A caregiver who has not been trained in diabetes management may make mistakes with potentially serious consequences.
6.1 What the caregiver must absolutely know
DYNSEO Visual Timer
The visual timer is a practical tool for structuring diabetes management routines: visual reminder of meal times, medication intake, or blood sugar measurement. For individuals with cognitive disorders who have lost the sense of time, it helps maintain essential routines independently for as long as possible.
Discover the visual timer7. Preventing cognitive decline in diabetic individuals
Preventing cognitive decline associated with diabetes is possible and involves a combined action on several levers. The effectiveness of multifactorial interventions is significantly higher than that of each isolated intervention.
Optimize blood sugar control without excessive strictness
Correct blood sugar control (HbA1c between 7 and 8 % depending on age and frailty) protects cerebral vessels. However, aiming for perfect blood sugar control at all costs in an elderly person exposes them to iatrogenic hypoglycemia that accelerates cognitive decline — the opposite of the intended goal.
Control associated cardiovascular risk factors
High blood pressure, dyslipidemia, obesity, smoking, and sedentary lifestyle are independent cognitive risk factors that add to that of diabetes. Their treatment and control are a priority in preventing cognitive decline in diabetic individuals.
Screen and treat sleep apnea syndrome
Screening for sleep apnea syndrome in diabetic individuals — particularly through nocturnal ventilatory polygraphy — and treatment with CPAP (continuous positive airway pressure) reduce nocturnal hypoxia and protect cognitive functions. This is one of the preventive interventions with the most favorable benefit/risk ratio.
Maintain regular physical activity
150 minutes of moderate activity per week (walking, swimming, cycling) improves blood sugar control, reduces chronic inflammation, and stimulates neurogenesis. It is the unique intervention that simultaneously produces the most significant metabolic and cognitive benefits.
Cognitively stimulate and maintain social connections
Regular cognitive stimulation (reading, games, DYNSEO applications) and maintaining an active social life are complementary prevention levers, reinforcing cognitive reserve that delays the clinical expression of decline.
8. Nutrition and the brain in diabetes
Nutrition plays a key role in both blood sugar control and cognitive health. These two objectives are fortunately compatible: the dietary recommendations for neuroprotection are essentially the same as those recommended for diabetes.
🥦 Neuroprotective foods to prioritize
- Fatty fish (sardines, mackerel, salmon): omega-3 DHA/EPA
- Leafy green vegetables (spinach, kale): folates, vitamin K
- Berries (blueberries, raspberries): polyphenols, antioxidants
- Nuts and almonds: vitamin E, plant-based omega-3
- Legumes: fiber, protein, low GI
- Extra virgin olive oil: polyphenols, monounsaturated fatty acids
- Turmeric: anti-inflammatory curcumin
⚠️ Foods to limit in elderly diabetic individuals
- Added sugars and ultra-processed products: inflammation, unstable blood sugar
- Saturated fats (processed meats, fatty cheeses): cardiovascular risk
- Excess salt: hypertension, worsening cerebral vascular issues
- Alcohol: masked hypoglycemia, direct neurotoxicity
- Sugary drinks (sodas, fruit juices): rapid blood sugar spike
DYNSEO Motivation Table
Maintaining a balanced diet and regular physical activity despite the challenges posed by diabetes and cognitive disorders requires sustained motivation. The DYNSEO motivation table helps set concrete and realistic goals, track progress week after week, and maintain commitment over time — whether for physical activity, dietary management, or cognitive stimulation.
Access the tool8. Therapeutic education for diabetic patients with cognitive disorders
Therapeutic education for patients (ETP) is the cornerstone of autonomous diabetes management. But when cognitive disorders set in, this autonomy may be compromised — and ETP programs must be rethought to remain accessible and effective. Adapting therapeutic education to the actual cognitive capacities of the patient is an ethical obligation and a clinical necessity.
8.1 Adapting ETP to cognitive disorders: fundamental principles
Assess cognitive abilities before any training
A simple assessment of cognitive functions (MoCA, clock test, 5 words) allows for adapting the complexity level of the ETP. A patient with moderate memory impairment will need enhanced visual aids, repetitions, and the involvement of the caregiver, while a patient with executive difficulties will need simplified procedures and explicit checklists.
Integrate the caregiver as a co-learner
The family must be included in ETP sessions, not just informed afterward. The relative or professional caregiver who shares the daily life of the person must master the same skills: recognizing hypoglycemia, checking blood sugar, administering insulin if necessary, managing emergency situations. This co-training is particularly valuable for individuals whose cognitive abilities are likely to evolve.
Use visual aids and compensatory tools
Weekly pill organizers with alarms, large-screen blood sugar readers with audible results, pre-printed tracking notebooks, laminated "what to do in case of hypoglycemia" sheets displayed in the kitchen — these tools compensate for memory difficulties and reduce the cognitive load of daily management. Digital applications for tracking diabetes (by choosing the simplest ones) can also help.
Simplify blood sugar goals and treatments
Too strict blood sugar goals present a high risk of hypoglycemia in a patient with cognitive disorders — who may not recognize the early signs or respond correctly. The primary care physician or endocrinologist must adapt blood sugar targets to the cognitive situation: less strict but better-managed goals are preferable to ideal goals that are poorly applied and lead to repeated hypoglycemia.
8.2 DYNSEO tools for adapted therapeutic education
📊 3-Column Table
- Structure information: situation / action to take / expected result
- Example: "Blood sugar < 0.7 → Take 3 sugars → Wait 15 min → Recheck"
- Simple visual support that replaces complex verbal instructions
- Adaptable to any recurring situation
⏱️ Visual Timer
- Visualize the passing time without counting mentally
- Waiting after taking sugar during hypoglycemia
- Time for insulin injection to be maintained
- Reminder of medication times for patients with prospective memory disorders
9. Care pathway: who to consult and how to coordinate
Managing diabetes associated with cognitive disorders requires multidisciplinary coordination that the French healthcare system does not always organize spontaneously. Knowing which professionals to consult and understanding how to articulate their interventions is valuable knowledge for patients and their families.
| Professional | Role in diabetes + cognitive disorders | Recommended frequency |
|---|---|---|
| Primary Care Physician | Overall follow-up, treatment adaptation, coordination, early screening, renewals | Every 3 months |
| Diabetologist / Endocrinologist | Treatment optimization, management of complications, insulin pump, new treatments | 1 to 2 times/year |
| Neuropsychologist / Geriatrician | Cognitive assessment, MCI or dementia diagnosis, cognitive stimulation advice, ETP adaptation | 1 time/year or if complaint |
| Dietitian-Nutritionist | Adapted dietary balance, management of dysphagia, nutritional deficits | 2 to 4 times/year |
| Coordination Nurse (IDEC) | Organization of home care, injections, monitoring, link with other professionals | As needed |
| Podiatrist | Monitoring of diabetic foot, prevention of wounds (risk of amputation × 3 if cognitive disorders) | Every 6 months |
| Ophthalmologist | Screening for diabetic retinopathy, AMD, glaucoma (frequent comorbidities) | Annual |
📱 DYNSEO cognitive tests: track progress between two consultations
DYNSEO offers online cognitive tests that allow diabetic individuals and their loved ones to monitor the evolution of cognitive functions between two medical consultations. Memory, attention, processing speed, executive functions — these tests do not replace a formal neuropsychological evaluation but serve as a useful complementary monitoring tool, especially for detecting changes that would warrant an early consultation. Find all the tests at dynseo.com/nos-tests/.
10. Primary prevention: act before the first cognitive signs
The link between diabetes and cognitive disorders is well established, so the prevention of cognitive decline should be integrated from the diabetes diagnosis — well before the appearance of the first signs. This prevention revolves around five axes that every diabetic patient should know and implement.
Optimal glycemic control
Maintain an HbA1c within the targets set with the doctor, without repeated hypoglycemia — both extremes (chronic hyper and hypoglycemia) accelerate cognitive decline. Glycemic variability is as harmful as the average level.
Regular physical activity
150 minutes of moderate activity per week improve insulin sensitivity, reduce cardiovascular risk, and stimulate hippocampal neurogenesis. This is the most powerful neuroprotective intervention available for diabetic patients.
Neuroprotective diet
The Mediterranean or MIND diet (Mediterranean + DASH combination) is the best documented for cognitive protection in diabetic patients. Rich in fatty fish, leafy green vegetables, nuts, and olive oil, and low in refined sugars and saturated fats.
Active cognitive stimulation
The cognitive reserve accumulated through learning, intellectual and cultural activities, and social relationships constitutes a powerful protective factor that delays the clinical expression of cognitive decline even in the presence of brain lesions related to diabetes.
11. Gestational diabetes and long-term cognitive risk: what we know
Beyond type 2 diabetes in the elderly, research is increasingly focusing on the effects of gestational diabetes — diabetes that occurs during pregnancy — on the long-term cognitive health of the mother and, potentially, on the cognitive development of the child.
11.1 Gestational diabetes and maternal risk
Women who have had gestational diabetes have a 7 to 10 times higher risk of developing type 2 diabetes within 10 years after giving birth, compared to women with normoglycemic pregnancies. However, as we have seen, T2D itself is a risk factor for cognitive decline. Preventing T2D after gestational diabetes — through diet, physical activity, and regular medical follow-up — is therefore also a prevention of long-term cognitive risk. Awareness often comes too late after childbirth, a period when medical monitoring focuses primarily on the infant.
11.2 Neonatal hypoglycemia and cognitive development
Gestational diabetes can lead to hypoglycemia in the newborn in the first hours of life. Severe or repeated neonatal hypoglycemia has been associated with learning difficulties in school age in several longitudinal studies. Glycemic monitoring of the newborn from a diabetic mother and the rapid correction of hypoglycemia are preventive measures that fall under maternity care — but that families would benefit from knowing.
12. The psychological dimension: living with the double burden
Receiving a diabetes diagnosis is already a significant psychological ordeal. Adding the announcement or suspicion of cognitive disorders can be experienced as a double collapse — a loss of control over one's body AND over one's thoughts. This reality deserves to be named and supported, not minimized.
12.1 Emotional distress of the diabetic patient with cognitive disorders
"Diabetes distress" is recognized as a distinct entity from depression: it refers to the emotional exhaustion related to the ongoing management of a complex chronic illness. It is present in 20 to 30% of diabetic patients and can even compromise treatment adherence. When cognitive disorders are added, the feeling of loss of control and competence can lead to shame, social withdrawal, and refusal of care. Early psychological support — from a psychologist trained in chronic illnesses or through support groups — is an essential component of care.
I checked my blood sugar twenty times a day and could no longer remember the number I had just read. I felt like my illness was stealing the tools I used to manage it.
— Anonymous patient testimony, 68 years old, diabetic for 12 years with mild cognitive disorder12.2 The EDITH app: stimulating with kindness
For diabetic patients over 65 who wish to engage in regular cognitive stimulation, the EDITH app from DYNSEO is particularly suitable. Designed for seniors, including those with early cognitive impairment, it offers accessible exercises, short sessions adapted to energy fluctuations, and an intuitive interface that generates neither frustration nor feelings of failure. It can be used independently or with the support of a loved one or healthcare professional.
Frequently asked questions about diabetes and cognitive disorders
Q1 Does diabetes really cause dementia, or is it just a coincidence?
The link between type 2 diabetes and the risk of dementia is established by large-scale longitudinal epidemiological studies. Diabetic individuals have a 40 to 65% increased risk of developing Alzheimer's disease, and a 100 to 150% increased risk of vascular dementia compared to the non-diabetic population. This link is causal (several direct biological mechanisms have been identified) and not simply due to a co-occurrence of two common pathologies. However, well-controlled diabetes and active management of associated risk factors significantly reduce this excess risk.
Q2 At what age should cognitive disorders be screened in a diabetic person?
Scientific societies recommend systematic screening for cognitive disorders starting at age 65 for all diabetic individuals, or earlier in case of memory complaints from the person or their relatives. A simple tool like the MoCA can be integrated into the annual diabetes assessment without significantly extending the consultation. For individuals with type 1 diabetes for more than 30 years, screening may be useful starting at age 55.
Q3 How to manage diabetes alone when having cognitive disorders?
Autonomous management of diabetes gradually becomes impossible with the worsening of cognitive disorders. The strategy is to simplify as much as possible (reduced therapeutic regimen, pillbox prepared by a relative or a professional, blood sugar measured only once or twice a day), to involve the caregiver in all therapeutic decisions, and to set up safety nets (alarms, teleassistance, nursing visits) for emergency situations. There is no shame in asking for help — it is a medical necessity.
Q4 Can antidiabetics themselves affect cognition?
Some antidiabetics have potential effects on cognition. Metformin, despite some studies suggesting a neuroprotective effect, can reduce long-term absorption of vitamin B12 — a factor contributing to cognitive decline. Sulfonylureas and insulins expose individuals to hypoglycemia, which is neurotoxic. Conversely, emerging data suggest a possible neuroprotective effect of GLP-1 analogs (liraglutide, semaglutide) and SGLT2 inhibitors — but this data is still insufficient to change practices. Discussing the cognitive profile of each molecule with the prescribing physician is an important step in therapeutic optimization.
Q5 Is the DYNSEO training suitable for freelance nurses who care for diabetic patients at home?
Yes, absolutely. The training "Diabetes and cognitive disorders: understanding the link and adapting professional practice" is designed for all healthcare professionals who support diabetic individuals on a daily basis, including freelance nurses. It covers mechanisms, simple screening tools to use during home visits, practical adaptations of care, and resources for caregivers. Qualiopi certified, it is fundable through OPCO for salaried professionals and through other schemes for freelancers.
Q6 My diabetic relative forgets to take their medication. What can I do concretely?
Several concrete strategies are available to you. First: organize a weekly pillbox (prepared by the caregiver or a nurse) and integrate medication taking into an already established daily routine (during breakfast, at the news time, etc.). Next: set up visual reminders (post-its on the kitchen table, alarm on the phone if the person knows how to use it). In case of frequent forgetfulness despite these measures, consider a freelance nurse for insulin injections and pillbox preparation — this can be covered by health insurance depending on medical needs.
Diabetes and cognition: a public health issue that should not be ignored
The link between diabetes and cognitive disorders is real, documented, and clinically significant. But it is not a fatality. By screening early, adapting care, integrating cognitive stimulation, and training professionals and caregivers, we can significantly improve the quality of life and autonomy of those affected.
Access the DYNSEO training →🎓 Training — Diabetes and Cognitive Disorders: Understanding the Link and Adapting Professional Practice
Qualiopi certified, 100% online, at your own pace, fundable through OPCO. For healthcare professionals and caregivers who support diabetic individuals with cognitive disorders. Mechanisms, screening, therapeutic adaptation, practical tools — everything you need for comprehensive and tailored care.
Access the training →Did this content help you? Support DYNSEO 💙
We are a small team of 14 people based in Paris. For 13 years, we have been creating free content to help families, speech therapists, care homes and healthcare professionals.
Your feedback is the only way we know if our work is useful. A Google review helps us reach other families, caregivers and therapists who need it.
One action, 30 seconds: leave us a Google review ⭐⭐⭐⭐⭐. It costs nothing, and it changes everything for us.
